`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`FAMY CARE LIMITED,
`Petitioner
`
`v.
`
`ALLERGAN, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-00567
`Patent 8,629,111
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S OPPOSITION TO
`PETITIONER’S MOTION FOR JOINDER
`
`
`
`Case IPR2017-00567
`Attorney Docket No: 13351-0008IPB
`
`On January 6, 2017, Petitioner, Famy Care Ltd. (“Famy Care”), filed an IPR
`
`
`
`petition and a motion to join its petition to IPR2016-01128 (“the Mylan IPR”).
`
`The Board granted the Mylan IPR on December 8, 2016 and issued a Scheduling
`
`Order setting August 17, 2017 as the date for oral argument.
`
`There are significant differences between Famy Care’s petition and Mylan’s
`
`petition. Famy Care’s petition includes declarations from two new experts rather
`
`than relying on Mylan’s one expert and introduces additional arguments.
`
`Moreover, Famy Care agrees only to use its “best efforts to cooperate with Mylan,
`
`and present consolidated papers wherever possible.” Petitioner’s Motion for
`
`Joinder, pp. 9-11. Nevertheless, Patent Owner agrees not to oppose joinder if
`
`Famy Care agrees to participate in the joined proceedings under the following
`
`conditions:
`
`1. Famy Care agrees to rely solely on Mylan’s expert;
`
`2. Famy Care agrees to consolidated briefing subject to the word count
`
`limits for a single party except for motions that involve only Famy Care;
`
`3. Famy Care agrees that cross-examination of Patent Owner’s witnesses
`
`will occur within the timeframe that the rules allot for one party; and
`
`4. Famy Care agrees that Mylan will conduct the oral argument.
`
`
`
`2
`
`
`
`Case IPR2017-00567
`Attorney Docket No: 13351-0008IPB
`Teva and Akorn have also filed motions to join the Mylan IPR, and have
`
`agreed to similar conditions for conducting the joined proceedings. See IPR2017-
`
`00578, Paper No. 3 (Teva) and IPR2017-00596, Paper No. 4 (Akorn). If Famy
`
`Care wishes to join, Famy Care should be able to participate only under the same
`
`conditions.
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`3
`
`
`
`
`
`Date:/February 6, 2017/
`
`
`Customer Number 26191
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`61432882.doc
`
`
`
`
`
`Case IPR2017-00567
`Attorney Docket No: 13351-0008IPB
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on February 6, 2017, a complete and entire copy of this Patent Owner
`
`Allergan, Inc.’s Opposition to Petitioner’s Motion for Joinder was provided via
`
`electronic service, to the Petitioner by serving the correspondence address of
`
`record as follows:
`
`Deanne M. Mazzochi
`William A. Rakoczy
`John D. Polivick
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street, Suite 500,
`Chicago, Illinois 60654
`
`dmazzochi@rmmslegal.com
`wrakoczy@rmmslegal.com
`jpolivick@rmmslegal.com
`FamyCareIPR@rmmslegal.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Jessica K. Detko/
`
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(612) 337-2516
`
`4
`
`
`
`
`
`
`
`
`
`